02.10.25 -- From JP Morgan: CDMOs Have A Change Of Heart

Join us on March 6th with Singota to explore strategies for scaling up drug development from bench to Phase 1 clinical trials. Learn how to navigate cold chain logistics, develop robust analytical methods, and avoid compromising your core values. Discover insights from Singota’s 20+ years of experience helping early-stage biopharma teams succeed. Click here to learn more.

New research shows that a common buffer used during diafiltration and ultrafiltration was at the heart of sieving losses, and using an alternative dramatically improved retention.

Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.

The drug development journey is long, expensive, resource-straining, and risky. Discover how to maximize the value of early-phase material and match your development path to your IND milestones.

Determining ideal media composition for a bacteria is critical because it fosters a satisfactory grow rate, allowing the bacteria to reach the required growth yield.

Biopharmaceutical sponsors can minimize to-clinic timelines by using innovative development strategies that trade potentially increased risk for time savings.

More than ever, the quality functions in biopharma manufacturing are under pressure due to regulatory and political scrutiny combined with a global market rife with complex quality standards.

Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.

This study reviews the results of three monoclonal antibody drug candidates utilizing a panel of small-scale, fast, and predictive tests used to evaluate therapeutic antibodies’ developability.

Delve into the specific challenges encountered in the development of high-concentration formulations and gain an overview of current state-of-the-art solutions for subcutaneous administration.

Join Boehringer Ingelheim in driving innovation, sustainability, and healthcare advancements in China, creating a healthier future for humans and animals alike.

Explore how cutting-edge technologies are transforming operational excellence with CAI on February 20th. See how these technologies can significantly reduce deviations, streamline processes, and drive continuous improvement as we share real-world examples and detailed case studies. Do not miss this opportunity to learn more about a digital toolkit for enhancing operational excellence across life sciences and mission critical facilities. Click here to learn more.

Utilizing Singota's International SCM services involves cost savings, risk mitigation, logistics support, and streamlined communication.

Backed by over 30 years of expe­rience and expertise in biological processing, we offer our customers a full “one-stop-shop” service package at all stages of development and production.

Here, we describe solutions for pharmaceutical labeling and how the process of procuring machinery for pharmaceutical labeling machines works at HERMA.

Xcellerex X-platform bioreactors offer modular, user-friendly designs with optimized scalability, adaptable automation, and standardization, enhancing productivity in pilot and cGMP cell culture operations.

Leverage the expertise and flexibility of a partner that empowers you to ensure regulatory compliance from the outset, with thorough characterization starting at the earliest stages.